These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 8938986)

  • 1. Association of murine splenocyte CD3 complex to the cytoskeleton: absence of modulation by exogenous fatty acids.
    Peck MD; Li Z; Jy W; Chu AJ; Bourguignon LY
    Cell Biol Int; 1996 Aug; 20(8):531-7. PubMed ID: 8938986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
    Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
    J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid unsaturation increases expression and capping of murine lymphocyte CD44 and CD45.
    Peck MD; Li Z; Han T; Wang W; Jy W; Ahn YS; Ziboh VA; Chu AJ; Bourguignon LY
    Nutrition; 1996 Sep; 12(9):616-22. PubMed ID: 8878171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the disassembly/assembly of the membrane skeleton in Madin-Darby canine kidney cells.
    Huotari V; Vaaraniemi J; Lehto VP; Eskelinen S
    J Cell Physiol; 1996 Apr; 167(1):121-30. PubMed ID: 8698829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced association of rat lymphocyte membrane proteins with the detergent-insoluble lymphocyte cytoskeletal matrix.
    Woda BA; McFadden ML
    J Immunol; 1983 Oct; 131(4):1917-9. PubMed ID: 6604752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD30 ligand (CD153) on murine activated T cells.
    Shimozato O; Takeda K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin.
    Bourguignon LY; Suchard SJ; Nagpal ML; Glenney JR
    J Cell Biol; 1985 Aug; 101(2):477-87. PubMed ID: 3874872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure and function of lymphocyte TCR/CD3 complex].
    Boćko D; Frydecka I
    Postepy Hig Med Dosw; 2003; 57(5):519-29. PubMed ID: 14737968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
    Michie AM; Rena G; Harnett MM; Houslay MD
    Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-mediated signals induce T cell dysfunction in vivo.
    Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
    J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the cytoskeletal regulatory protein alpha-adducin as a target of T cell receptor signaling.
    Lu Q; Liu X; Trama J; Roti MA; Go WY; Ho SN
    Mol Immunol; 2004 Jun; 41(4):435-47. PubMed ID: 15163540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes.
    Berg NN; Puente LG; Dawicki W; Ostergaard HL
    J Immunol; 1998 Sep; 161(6):2919-24. PubMed ID: 9743353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation.
    Luton F; Buferne M; Legendre V; Chauvet E; Boyer C; Schmitt-Verhulst AM
    J Immunol; 1997 May; 158(9):4162-70. PubMed ID: 9126976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A permissive geometry model for TCR-CD3 activation.
    Minguet S; Schamel WW
    Trends Biochem Sci; 2008 Feb; 33(2):51-7. PubMed ID: 18201888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the relevance of microtubules and of microfilament-dependent processes for triggering lymphocyte activation.
    Lother H; Blitstein-Willinger E; Diamantstein T
    Z Immunitatsforsch Immunobiol; 1979 Mar; 155(4):346-58. PubMed ID: 572609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of reactive nitrogen intermediates and transforming growth factor-beta produced by immunosuppressive macrophages in the expression of suppressor activity against T cell proliferation induced by TCR stimulation.
    Shimizu T; Cai S; Tomioka H
    Cytokine; 2005 Apr; 30(1):7-13. PubMed ID: 15784407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lymphoma plasma membrane-associated protein with ankyrin-like properties.
    Bourguignon LY; Walker G; Suchard SJ; Balazovich K
    J Cell Biol; 1986 Jun; 102(6):2115-24. PubMed ID: 2940251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton.
    Kammer GM; Smith JA; Mitchell R
    J Immunol; 1983 Jan; 130(1):38-44. PubMed ID: 6600189
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of lymphocyte proliferation by free fatty acids. II. Toxicity of stearic acid towards phytohaemagglutinin-activated T cells.
    Buttke TM; Cuchens MA
    Immunology; 1984 Nov; 53(3):507-14. PubMed ID: 6333387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.